CHMP Recommends Approval of Henlius and Intas' Serplulimab for ES-SCLC in Europe
The CHMP has issued a positive opinion for serplulimab (HETRONIFLY®), recommending its approval in Europe for ES-SCLC treatment.
© Copyright 2025. All Rights Reserved by MedPath